A major new study out of the VA system has found that veterans diagnosed with melanoma face a 47% higher risk of later developing Parkinson's disease compared to veterans without melanoma — adding fresh evidence to a growing body of research suggesting the two diseases are biologically linked.

While it's been known that Parkinson's patients have an elevated melanoma risk, the reverse relationship has been murkier. This study, published in the Journal of the American Academy of Dermatology, helps clarify that connection using one of the largest datasets to date — over 7.4 million veterans aged 50 and older tracked between 2009 and 2022.

Researchers found that certain subgroups faced even steeper risks, particularly veterans exposed to combat-era toxins. The findings point to a possible shared biological mechanism between the two diseases, opening doors for future preventive or therapeutic research.

By the Numbers:

• 1.47x higher Parkinson's risk for veterans with melanoma
• 4.61x higher risk for Persian Gulf War veterans with melanoma
• 2.53x higher risk for Vietnam Era veterans with melanoma
• 1.65x higher risk for those exposed to Agent Orange
• 65,496 veterans had a primary melanoma diagnosis out of 7.4M+ studied

Why it matters: Dermatologists treating melanoma patients — especially veterans — should be alert to early Parkinson's symptoms like resting tremor or shuffling gait, and consider timely referrals. Understanding this link could eventually lead to shared treatment or prevention strategies for both conditions.